Vor Biopharma
VOR
VOR
59 hedge funds and large institutions have $326M invested in Vor Biopharma in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
19% less capital invested
Capital invested by funds: $400M → $326M (-$74.3M)
64.5% less ownership
Funds ownership: 155.69% → 91.18% (-65%)
Holders
59
Holding in Top 10
5
Calls
$103K
Puts
$6K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.75M | |
| 3 | +$1.52M | |
| 4 |
BlackRock
New York
|
+$1.24M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$803K |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$847K | |
| 3 | -$790K | |
| 4 |
AIC
AWM Investment Company
New York
|
-$665K |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$512K |